Drugs / Bone Marrow Concentrate
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04205656 | Jan 2020 → Jul 2024 overdue | osteoarthritis, knee | Steadman Philippon Research Institute | Active not recruiting | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04559295 | Nov 2018 → Mar 2020 | arthropathy, intervertebral disk degenerative disorder, radiculopathy, spinal stenosis | Stem Cures | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03876795 | Nov 2019 → Mar 2023 | osteoarthritis, knee | Rizzoli Orthopaedic Institute | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03223701 | Sep 2017 → Sep 2018 | intervertebral disk degenerative disorder, spinal stenosis, spondylolisthesis | Seton Healthcare Family | Withdrawn | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT03790189 | Jan 2019 → Jul 2021 | chondromalacia, osteoarthritis, knee | Istituto Clinico Humanitas | Unknown | No outcome recorded |
| — | NCT05191732 | Aug 2018 → Jul 2020 | — | Kaohsiung Medical University Chung-Ho Memorial Hospital | Completed | No outcome recorded |
| — | NCT03517761 | Mar 2018 → Dec 2030 expected | nervous system injury | Regenexx, LLC | Recruiting | No outcome recorded |
| — | NCT01603836 | Feb 2009 → Mar 2010 | spondylosis | Hospital Znojmo | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2024-10-23 | Celling Biosciences | The Power of Bone Marrow Concentrate for Rotator Cuff Disorders cellingbiosciences.com ↗ |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bone Marrow Concentrate | “the aim of the present pilot trial is to assess the safety and describe the clinical outcome following concurrent intra-articular and subchondral bone application of Bone...” NCT03790189 ↗ |
| Known as | BMC | “the aim of the present pilot trial is to assess the safety and describe the clinical outcome following concurrent intra-articular and subchondral bone application of Bone...” NCT03790189 ↗2“Bone marrow concentrate (BMC) (Dosage form: APA-15Q)” NCT05191732 ↗ “Biological: Bone Marrow Concentrate (BMC)” NCT04205656 ↗ |
| Modality | Cell therapy | “The use of autologous mesenchymal stem cell (MSCs) in form of the BMC in combination with allograft is an effective option how to enhance the Posterolateral Fusion (PLF) healing.” NCT01603836 ↗ |
| Route | Other | “in the interbody space of a TLIF” NCT03223701 ↗ |